Insider · CIK 0001512119
Thomas A. Raffin
director
Files at LUMOS PHARMA, INC., AKYA (Akoya Biosciences, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stockindirect: Thomas A. Raffin Living Trust dated March 29, 2017 | -234,592 | - | - | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stockindirect: See footnote 3 | -1,737,712 | - | - | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stockindirect: See footnote 4 | -15,937,535 | - | - | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -16,860 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -30,549 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -56,322 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Common Stock | -9,406 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,345 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,328 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,684 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,431 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,910 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,777 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,439 | - | - | 0 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.